18/03/2021
Oxford-AstraZeneca vaccine update
Wakaalada midowga yurub u qaabilsan eegista iyo hubinta badqabka iyo tayada daawooyinka ee layiraahdo Europeans medicines agency ( EMA) ayaa dib u eegis ku sameesay talaalka covid19 ka ee oxford- AstraZeneca waxay na dib u eegistooda ku ogaadeen in ilaa hada aan la arkin wax xariir ah oo ka dhaxeeyo talaalka Oxford-AstraZeneca iyo xijireysiga dhiiga (blood clotting) sidaas awgeed na talaalkan Oxford-AstraZeneca yahay mid aan khatar caafimaad laheen
Waxay kale oo ay wakaaladu cadeysay in faaiidooyinka talaalkan Oxford-AstraZeneca ay aad uga badantahay saameenta togan ee aadka u yar ee uu yeelan karo talaalkan
Hay'adda caafimaadka aduunka (WHO) aya ayadana khamiisti ina dhaaftay aduunka u sheegay in talaakan Oxford-AstraZeneca uu yahay mid aan wax khatar ah laheen walibana uu wax tar fiican oo ka hortaga cudurka covid19 ah leeyahay waxayna sheegtay in ay baaritaan ku wado maalinta jimcada ah na ay so saari doonaan natiijada baaritaankooda
Waxaan bulshadeena soomaaliyeed xasuusin laha in ay dhageestaan talooyinka dadka cilmiga u leh caafimaadka oo aysan ka dhigin arintan wax ruux walba uu fikir ka dhiiban karo
Aan dhageesano talada khubaradeena caafimaadka (health experts) iyo wasaarada caafimaadka soomaaliya oo aan ka faaiideysano talaalka la inaku deeqay
Link gan hoose waxaad ka heli karta natiijadii baaritaanka European medicines agency https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots
Abdullahi Hussein Hassan.
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low platelets